4.7 Article

A Supramolecular Nanoparticle of Pemetrexed Improves the Anti-Tumor Effect by Inhibiting Mitochondrial Energy Metabolism

Journal

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fbioe.2021.804747

Keywords

supramolecular nanoparticle; pemetrexed; metabolism; mitochondrial; tumor therapy

Funding

  1. National Natural Science Foundation of China [81901590, 31900998]
  2. Key Scientific Research Foundation of the Higher Education Institutions of Henan Province [20A310014]

Ask authors/readers for more resources

Supramolecular nanoparticles consisting of peptides and drugs, particularly RGD-conjugated molecular nanoparticles containing the anticancer drug PEM, show enhanced cytotoxic activity and antitumor efficacy compared to PEM alone. These nanoparticles have great potential for application in lung cancer therapy by promoting tumor apoptosis and decreasing mitochondrial energy metabolism.
In recent years, supramolecular nanoparticles consisting of peptides and drugs have been regarded as useful drug delivery systems for tumor therapy. Pemetrexed (PEM) is a multitarget drug that is effective for many cancers, such as non-small cell lung cancer. Here, RGD-conjugated molecular nanoparticles mainly composed of an anticancer drug of PEM (PEM-FFRGD) were prepared to deliver PEM to tumors. The peptide could self-assemble into a nanoparticle structure with diameter of about 20 nm. Moreover, the nanoparticle showed favorable solubility and biocompatibility compared with those of PEM, and the MTT test on A549 and LLC cells showed that the PEM-FFRGD nanoparticles had stronger cytotoxic activity than PEM alone. Most importantly, the nanoparticle could promote tumor apoptosis and decrease mitochondrial energy metabolism in tumors. In vivo studies indicated that PEM-FFRGD nanoparticles had enhanced antitumor efficacy in LLC tumor-bearing mice compared to that of PEM. Our observations suggested that PEM-FFRGD nanoparticles have great practical potential for application in lung cancer therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available